003042.SHE Shandong Sino-Agri United Biotechnology Co Ltd
- Market cap
- CNY 1.70B
- P/E
- -
- P/B
- 1.55x
- ROE
- -15.3%
- Dividend yield
- 1.19%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 003042.SHE undervalued?
Graham numberThe Graham number of Shandong Sino-Agri United Biotechnology Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shandong Sino-Agri United Biotechnology Co Ltd fundamental analysis
No fundamental analysis for Shandong Sino-Agri United Biotechnology Co Ltd yet.
Shandong Sino-Agri United Biotechnology Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shandong Sino-Agri United Biotechnology Co Ltd
Shandong Sino-Agri United Biotechnology Co.,Ltd engages in the development and production of pesticide intermediates and preparation products in China. It offers imidacloprid, acetamiprid, (E)-nitenpyram, pyridaben, intermediates, pesticides, fungicides, and herbicides. The company also exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States. Shandong Sino-Agri United Biotechnology Co.,Ltd was founded in 2006 and is based in Jinan, …
Full company profileShandong Sino-Agri United Biotechnology Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shandong Sino-Agri United Biotechnology Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 952M | 1.12B | 1.41B | 1.37B | 1.57B | 1.63B | 1.93B | 1.68B | 2.01B | 1.86B | 2.17B |
| Gross Profit | 271M | 367M | 550M | 486M | 382M | 361M | 362M | 81.9M | 160M | 195M | 228M |
| Operating Income | 95.3M | 127M | 283M | 163M | 119M | 109M | 71.7M | -237M | -136M | -110M | -88.5M |
| EBITDA | 153M | 228M | 391M | 284M | 250M | 249M | 252M | -35.1M | 84.2M | 93.6M | -154M |
| Net Income | 72.9M | 106M | 244M | 147M | 104M | 98.6M | 73.1M | -192M | -122M | -137M | -167M |
| EPS | 1.04 | 1.13 | 2.53 | 1.38 | 0.97 | 0.74 | 0.51 | -1.35 | -0.86 | -0.96 | -1.17 |
| Balance Sheet | |||||||||||
| Total Assets | 1.41B | 1.61B | 1.79B | 1.89B | 2.30B | 3.22B | 3.54B | 3.74B | 3.93B | 3.82B | 3.93B |
| Total Liabilities | 922M | 1.19B | 990M | 972M | 1.30B | 1.59B | 1.86B | 2.27B | 2.58B | 2.60B | 2.83B |
| Shareholders' Equity | 485M | 428M | 800M | 914M | 996M | 1.63B | 1.68B | 1.47B | 1.35B | 1.22B | 1.10B |
| Cash & Short-term Investments | 147M | 349M | 264M | 151M | 283M | 576M | 316M | 572M | 425M | 169M | 327M |
| Total Debt | 494M | 574M | 350M | 346M | 506M | 521M | 571M | 800M | 928M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 80.4M | 244M | 243M | 96.2M | 115M | 54.4M | -40.4M | 86.9M | 105M | 13.9M | - |
| Capital Expenditure | 59.7M | 43.1M | 12.1M | 92.5M | 90.9M | 245M | 129M | 135M | 175M | 129M | 18.6M |
| Free Cash Flow | 20.7M | 201M | 231M | 3.72M | 23.9M | -190M | -170M | -48.0M | -69.8M | -116M | -79.5M |
| Ratios | |||||||||||
| ROE | 15.0% | 24.9% | 30.5% | 16.1% | 10.4% | 6.1% | 4.4% | -13.1% | -9.0% | -11.2% | -15.3% |
| ROA | 5.2% | 6.6% | 13.6% | 7.8% | 4.5% | 3.1% | 2.1% | -5.1% | -3.1% | -3.6% | -4.3% |
| Net Profit Margin | 7.7% | 9.5% | 17.2% | 10.8% | 6.6% | 6.1% | 3.8% | -11.5% | -6.1% | -7.3% | -7.7% |
| Debt to Equity | 1.02x | 1.34x | 0.44x | 0.38x | 0.51x | 0.32x | 0.34x | 0.54x | 0.69x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shandong Sino-Agri United Biotechnology Co Ltd dividends
- Dividend yield
- 1.19%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Jun 21, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 20.2M | 0.14 | - |
| 2024 | CNY 25.1M | 0.18 | - |
| 2023 | CNY 35.2M | 0.25 | - |
| 2022 | CNY 21.9M | 0.15 | 30.0% |
| 2021 | CNY 20.1M | 0.15 | 20.4% |
| 2020 | CNY 24.7M | 0.23 | 23.8% |
| 2019 | CNY 32.9M | 0.31 | 22.3% |
| 2018 | 70.9M | 0.74 | 29.1% |
| 2017 | 67.7M | 0.72 | 63.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.3:1 on Jun 22, 2022.
Who owns Shandong Sino-Agri United Biotechnology Co Ltd
- Insiders 56.02%
- Institutions 2.52%
- Public & others 41.46%
- Shares outstanding 142M
- Free float 67.2M
Shandong Sino-Agri United Biotechnology Co Ltd company profile
- Company name
- Shandong Sino-Agri United Biotechnology Co Ltd
- Ticker
- 003042.SHE
- ISIN
- CNE100004K45
- Exchange
- Shenzhen Stock Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,800
- Fiscal year end
- December
- Address
- No. 9999, Jingshi Road, Jinan, China, 250014
- Phone
- 86 53 1889 77085
- Website
- sdznlh.com
About Shandong Sino-Agri United Biotechnology Co Ltd
Shandong Sino-Agri United Biotechnology Co.,Ltd engages in the development and production of pesticide intermediates and preparation products in China. It offers imidacloprid, acetamiprid, (E)-nitenpyram, pyridaben, intermediates, pesticides, fungicides, and herbicides. The company also exports its products to Southeast Asia, South Asia, the Middle East, Europe, and the United States. Shandong Sino-Agri United Biotechnology Co.,Ltd was founded in 2006 and is based in Jinan, China.
Shandong Sino-Agri United Biotechnology Co Ltd management
7- Mr. Ning LiGM & Director · born 1974
- Mr. Qiang LiFinancial Director · born 1982
- Mr. Jianfeng TangChief Engineer · born 1971
- Mr. Shijin YanDeputy GM & Board Secretary · born 1984
- Mr. Hongsheng JiangDeputy General Manager · born 1976
- Ms. Wenli WangDeputy General Manager · born 1981
- Yeli ChenAccounting Supervisor